IP Verse

Engineered Extracellular Vesicles And Uses Thereof - EP3672614

The patent EP3672614 was granted to Codiak Biosciences on Oct 6, 2021. The application was originally filed on May 22, 2019 under application number EP19731027A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3672614

CODIAK BIOSCIENCES
Application Number
EP19731027A
Filing Date
May 22, 2019
Status
Opposition Rejected
Oct 11, 2024
Grant Date
Oct 6, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CILOAJul 5, 2022ICOSAADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2018US48026-
DESCRIPTIONWO2018US61679-
DESCRIPTIONUS10195290
DESCRIPTIONUS4683195
DESCRIPTIONWO2019040920
EXAMINATIONWO2016138525
EXAMINATIONWO2019099942
EXAMINATIONWO2020041720
INTERNATIONAL-SEARCH-REPORTUS2018015182
INTERNATIONAL-SEARCH-REPORTWO2018039119
INTERNATIONAL-SEARCH-REPORTWO2018112154
OPPOSITIONWO2011036416
OPPOSITIONWO2016138525
OTHERUS9611481
OTHERWO2011036416

Non-Patent Literature (NPL) Citations (51) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALTSCHUL 20 et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10-
DESCRIPTION- ALVAREZ-ERVITI, L. et al., Nat. Biotechnol., (20110000), vol. 29, no. 4, pages 341 - 345-
DESCRIPTION- BANASZYNSKI et al., J Am Chem Soc., (20050406), vol. 127, no. 13, pages 4715 - 21-
DESCRIPTION- CAREYSUNDBERG, Molecular Cloning: A Laboratory Manual, Cold Springs Harbor Laboratory, (19920000), vol. A, B-
DESCRIPTION- CAUSSINUS EKANCA OAFFOLTER M, "Fluorescent fusion protein knockout mediated by anti-GFP nanobody", Nat Struct Mol Biol., (20111211), vol. 19, no. 1, pages 117 - 21-
DESCRIPTION- CORPET et al., Nuc. Acids Res., (19880000), vol. 16, pages 10881 - 90-
DESCRIPTION- CROOKE, Antisense drug Technology: Principles, Strategies and Applications, CRC Press, (20070000), vol. 154, 155-
DESCRIPTION- DNA Cloning, (19850000), vol. I, II-
DESCRIPTION- DOBELI et al., J. Biotechnology, (19880000), vol. 7, pages 199 - 216-
DESCRIPTION- GAYLE, J. Biol. Chem, (19930000), vol. 268, pages 22105 - 22111-
DESCRIPTION- GOTTLIEB-ABRAHAM et al., Mol. Biol. Cell, (20161201), vol. 27, no. 24, pages 3926 - 3936-
DESCRIPTION- Handbook Of Experimental Immunology, Cold Spring Harbor Laboratory Press, (19860000), vol. I-IV-
DESCRIPTION- HIGGINSSHARP, CABIOS, (19890000), vol. 5, pages 151 - 3-
DESCRIPTION- HIGGINSSHARP, Gene, (19880000), vol. 73, no. 15, pages 237 - 44-
DESCRIPTION- HUANG et al., Comp. Appl. BioSci., (19920000), vol. 8, pages 155 - 65-
DESCRIPTION- KUYPERS et al., Biohim Biophys Acta, (19850000), vol. 819, page 170-
DESCRIPTION- LIM et al., J Biol Chem., (19940325), vol. 269, no. 12, pages 9006 - 10-
DESCRIPTION- LIMPEABODY, RNA. Nucleic Acids Res., (19940911), vol. 22, no. 18, pages 3748 - 52-
DESCRIPTION- MAAS, S.L.N. et al., Trends. Cell Biol., (20170000), vol. 27, no. 3, pages 172 - 188-
DESCRIPTION- MEI et al., Blood, (20100000), vol. 116, pages 270 - 79-
DESCRIPTION- NEEDLEMANWUNSCH, J. Mol. Bio., (19700000), vol. 48, page 443-
DESCRIPTION- PEARSON et al., Meth. Mol. Biol., (19940000), vol. 24, pages 307 - 31-
DESCRIPTION- PEARSONLIPMAN, Methods in Mol. Biol., (19880000), vol. 24, pages 307 - 31-
DESCRIPTION- R. AASLAND et al., FEBS Letters, (20020000), vol. 513, pages 141 - 144-
DESCRIPTION- RON et al., J. Biol. Chem., (19930000), vol. 268, pages 2984 - 2988-
DESCRIPTION- SENTI et al., PNAS, (20080000), vol. 105, no. 46, page 17908-
DESCRIPTION- SMITHWATERMAN, Adv. Appl. Math., (19810000), vol. 2, page 482-
DESCRIPTION- SPIESS et al., Molecular Immunology, (20150000), vol. 67, pages 95 - 106-
DESCRIPTION- "Uniprot", Database accession no. P80723-
DESCRIPTION- ZETSCHE BVOLZ SEZHANG F, "A split-Cas9 architecture for inducible genome editing and transcription modulation", Nat Biotechnol., (20150200), vol. 33, no. 2, doi:doi:10.1038/nbt.3149, pages 139 - 42, XP055227889
EXAMINATION- Ryo Tamura, "1. Study on the Effector Domain of MARCKS Protein as a Cell Penetrating Peptide; 2. Development of the Photoactivatable Prodrugs of Doxazolidine", (20170101), URL: https://scholar.colorado.edu/concern/graduate_thesis_or_dissertations/n583xv070, (20201012), XP055739069-
INTERNATIONAL-SEARCH-REPORT- PABLO GARCÍA-MANRIQUE ET AL, "Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes", JOURNAL OF EXTRACELLULAR VESICLES, (20180117), vol. 7, no. 1, doi:10.1080/20013078.2017.1422676, page 1422676, XP055541251 [X] 1-82 * abstract * * page 1, column l, paragraph 1 - page 15, column l, paragraph 1 * [Y] 1-82 [I] 1-82
INTERNATIONAL-SEARCH-REPORT- BENCE GYÖRGY ET AL, "Therapeutic Applications of Extracellular Vesicles: Clinical Promise and Open Questions", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY., US, (20141003), vol. 55, no. 1, doi:10.1146/annurev-pharmtox-010814-124630, ISSN 0362-1642, pages 439 - 464, XP055619511 [X] 1-82 * abstract * * page 2, paragraph 1 - page 18, paragraph 1 * [Y] 1-82 [I] 1-82
INTERNATIONAL-SEARCH-REPORT- JING LI ET AL, "Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components", PLOS ONE, (20160920), vol. 11, no. 9, doi:10.1371/journal.pone.0163043, page e0163043, XP055619543 [X] 1-82 * abstract * * page 1, paragraph 1 - page 12, paragraph 5 * [Y] 1-82 [I] 1-82
OPPOSITION- "BASP1_HUMAN", UniProtKB, (20180912), Database accession no. P80723, XP055944880-
OPPOSITION- "BASP1_HUMAN", UniProtKB, (20190213), Database accession no. P80723, XP055944883-
OPPOSITION- RESH MD, "Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins", Biochim Biophys Acta, (19990000), vol. 1451, no. 1, doi:10.1016/S0167-4889(99)00075-0, pages 1 - 16, XP004278020
OPPOSITION- MOSEVITSKY MI et al., "The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties", Biochimie, (19970000), vol. 79, no. 6, doi:10.1016/S0300-9084(97)80032-6, pages 373 - 384, XP002248480
OPPOSITION- MCLAUGHLIN S et al., "The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions", Trends Biochem Sci., (19950000), vol. 20, no. 7, doi:10.1016/S0968-0004(00)89042-8, pages 272 - 276, XP004222280
OPPOSITION- JIANG H et al., "Protein lipidation: occurrence, mechanisms, biological functions, and enabling technologies", Chem Rev., (20180000), vol. 118, no. 3, pages 919 - 988, XP055944897
OPPOSITION- SIGAL CT et al., "Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids", Proc Natl Acad Sci USA., (19940000), vol. 91, no. 25, doi:10.1073/pnas.91.25.12253, pages 12253 - 12257, XP055533620
OPPOSITION- SHEN B et al., "Protein targeting to exosomes/microvesicles by plasma membrane anchors", J Biol Chem., (20110000), vol. 286, no. 16, doi:10.1074/jbc.M110.208660, pages 14383 - 14395, XP055498705
OPPOSITION- BALASUBRAMANIAM M et al., "New insights into HIV assembly and trafficking", Physiology (Bethesda, (20110000), vol. 26, no. 4, doi:10.1152/physiol.00051.2010, pages 236 - 251, XP055832477
OTHER- "Gene description for Basp1", Vesiclepedia, URL: http://microvesicles.org/gene_summary?gene_id=70350-
OTHER- Lahiru Gangoda , Michael Liem , Ching-Seng Ang , Shivakumar Keerthikumar , Christopher G Adda , Belinda S Parker , Suresh Mathivanan, "Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential", Proteomics . , (20171200), vol. 17, no. 23-24-
OTHER- MOSEVITSKY M I; ET AL, "The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties", Biochimie, (19970600), vol. 79, no. 6, doi:10.1016/S0300-9084(97)80032-6, pages 373 - 384, XP002248480
OTHER- McLaughlin S; Aderem A, "The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions", Trends in Biochemical Sciences,, (19950700), vol. 20, no. 7, pages 272 - 276, XP004212769
OTHER- Catherine T Sigal; Zhou Wenjun; Buseri Carolyn A; Mclaughlint Stuart; Resh Marilyn D; Buchanan John M, "Amino- terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids", Proc Natl Acad Sci USA., (19941206), vol. 91, no. 25, pages 12253 - 12257, XP055533620
OTHER- Beiyi Shen; Ning Wu; Jr-Ming Yang; Stephen J Gould, "Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors", Journal of Biological Chemistry,, (20110207), vol. 286, no. 16, pages 14383 - 14395, XP055498705
OTHER- Balasubramaniam Muthukumar, Freed Eric O., "New insights into HIV assembly and trafficking", Physiology, (20110800), vol. 26, no. 4, pages 236 - 251, XP055832477
OTHER- Potolicchio Ilaria, Carven Gregory J., Xu Xiaonan, Stipp Christopher, Riese Richiard J., Stern Lawrence J., Santambrogio Laura, "Proteomic Analysis of Microglia-DerivedExosomes: Metabolic Role of the Aminopeptidase CD13 in Neuropeptide Catabolism", The Journal of Immunology, (20050815), vol. 175, no. 4, pages 2237 - 2243, XP055832481

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents